1. The presence of granulocytopenia or thrombocytopenia at the start of treatment does not
contraindicate Vincristin therapy.
治疗开始时出现粒细胞减少或血小板减少,并不禁忌用长春新碱治疗。
2. The presence of granulocytopenia or thrombocytopenia at the start of treatment does not
contraindicate vincristine therapy.
治疗开始时出现粒细胞减少或血小板减少,并不表示不适用长春花碱。
3. In particular, the presence of esophageal varices may
contraindicate prophylaxis as it is associated with postoperative hemorrhage.
特别是有食管静脉曲张时表明预防性抗血栓治疗与术后出血有关系。